DENTSPLY SIRONA (NASDAQ:XRAY) Share Price Crosses Below Fifty Day Moving Average – What’s Next?

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) shares passed below its fifty day moving average during trading on Thursday. The stock has a fifty day moving average of $9.48 and traded as low as $9.23. DENTSPLY SIRONA shares last traded at $9.24, with a volume of 5,492,190 shares.

Wall Street Analysts Forecast Growth

A number of brokerages have weighed in on XRAY. JPMorgan Chase & Co. reduced their price target on shares of DENTSPLY SIRONA from $12.00 to $10.00 and set a “neutral” rating on the stock in a research report on Friday, November 6th. Weiss Ratings reissued a “sell (e+)” rating on shares of DENTSPLY SIRONA in a research report on Friday, October 30th. Zacks Research downgraded shares of DENTSPLY SIRONA from a “hold” rating to a “strong sell” rating in a research note on Monday. Barclays raised their price target on shares of DENTSPLY SIRONA from $9.00 to $11.00 and gave the company an “underweight” rating in a report on Monday, August 24th. Finally, Mizuho reduced their target price on DENTSPLY SIRONA from $14.00 to $12.00 and set a “neutral” rating for the company in a research note on Thursday, October 22nd. Three investment analysts have rated the stock with a Buy rating, seven have issued a Hold rating and four have assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Reduce” and a consensus target price of $12.42.

DENTSPLY SIRONA Stock Down 5.3%

The business’s 50 day simple moving average is $9.48 and its 200 day simple moving average is $11.22. The company has a market capitalization of $1.83 billion, a PE ratio of -14.90, a price-to-earnings-growth ratio of 1.43 and a beta of 0.87. The company has a quick ratio of 1.04, a current ratio of 1.63 and a debt-to-equity ratio of 1.47.

DENTSPLY SIRONA (NASDAQ:XRAY) last announced its quarterly earnings results on Thursday, November 5th. The medical instruments supplier reported $0.29 EPS for the quarter, missing the consensus estimate of $0.31 by ($0.02). DENTSPLY SIRONA had a negative net margin of 3.38% and a positive return on equity of 20.21%. The firm had revenue of $836.00 million during the quarter, compared to the consensus estimate of $861.68 million. During the same period in the previous year, the firm posted $0.37 EPS. The company’s quarterly revenue was down 7.5% compared to the same quarter last year. DENTSPLY SIRONA has set its FY 2026 guidance at 1.200-1.300 EPS. As a group, analysts forecast that DENTSPLY SIRONA Inc. will post 1.21 EPS for the current year.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently made changes to their positions in the stock. BlackRock Inc. bought a new stake in DENTSPLY SIRONA during the 2nd quarter worth approximately $283,405,000. Southpoint Capital Advisors LP bought a new position in DENTSPLY SIRONA in the 1st quarter valued at $116,000,000. Edmond DE Rothschild Holding S.A. raised its position in DENTSPLY SIRONA by 1.4% in the 3rd quarter. Edmond DE Rothschild Holding S.A. now owns 4,568,300 shares of the medical instruments supplier’s stock valued at $40,475,000 after purchasing an additional 65,000 shares during the last quarter. Paradigm Capital Management Inc. NY bought a new position in DENTSPLY SIRONA in the 2nd quarter valued at $39,775,000. Finally, Dimensional Fund Advisors LP boosted its stake in DENTSPLY SIRONA by 31.4% in the first quarter. Dimensional Fund Advisors LP now owns 3,559,388 shares of the medical instruments supplier’s stock worth $41,284,000 after purchasing an additional 850,261 shares in the last quarter. 95.70% of the stock is owned by institutional investors.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc. develops, manufactures and markets products and technologies for dental professionals. Its portfolio includes dental equipment and imaging systems, digital dentistry and CAD/CAM solutions, dental implants, endodontic and restorative products, and supplies used in preventive care. The company serves dental practices, laboratories and other customers around the world. Its products support a range of clinical activities, including diagnosis, treatment planning, restorative dentistry and oral hygiene.